Whalesbook
Nephrocare Health Services Ltd has filed a writ petition with the High Court of Jammu & Kashmir and Ladakh to challenge a Goods and Services Tax (GST) demand totaling approximately ₹2.51 crore. This includes ₹1.46 crore in tax, ₹0.90 crore in interest, and ₹0.15 crore in penalty.
The company is disputing the validity of this demand. Nephrocare's appeal against an earlier tax order was rejected by authorities on grounds of delay. The company maintains the demand is not sustainable and stated it expects no material financial impact from this legal challenge.
GST authorities have initiated recovery proceedings against the dialysis services provider, including attachment notices.
The sequence leading to the writ petition started with a Show Cause Notice on September 18, 2024. This was followed by an Order-in-Original on January 13, 2025, and the rejection of Nephrocare's appeal on March 12, 2026.
This tax dispute highlights the complexities companies face. If the High Court rules against Nephrocare, it could be liable for significant financial obligations, impacting its profitability and cash flow. Shareholders will be monitoring the court's decision.
Nephrocare Health Services is a significant provider of dialysis care across India and Asia, operating more than 500 clinics. In the past, the company faced regulatory scrutiny; in January 2014, it and Max Healthcare Institute Ltd were debarred by the Delhi government for one year from participating in government tenders for dialysis machines, reportedly due to alleged bid process interference.
The company's current financial obligation depends on the writ petition's outcome. Key risks involve an adverse court ruling upholding the ₹2.51 crore demand and the ongoing recovery actions by GST authorities.